Zebinix: Phase III data

Data from the PP population of 785 patients with newly diagnosed partial-onset seizures in a double-blind, Portuguese Phase III trial showed that once-daily oral Zebinix met the primary endpoint

Read the full 290 word article

How to gain access

Continue reading with a
two-week free trial.